News Molecule Catalyst and UTM to crowdfund psychedelics research with...

Molecule Catalyst and UTM to crowdfund psychedelics research with blockchain

-

- Advertisment -

The University of Toronto Mississauga (UTM) is financing a study into the psychedelic psilocybin with the help of decentralized fundraising platform Molecule Catalyst, in the first attempt to fund a clinical trial into psychedelics using decentralized finance.

According to a recent post on the Molecule blog, the effort will be a joint collaboration between Molecule Catalyst, Rotem Petranker and Thomas Anderson, directors at the University of Toronto Mississauga Psychedelic Studies Research Program (PSRP).

Fundraising with blockchain

Through its partnership with Molecule Catalyst, UTM hope to raise an undisclosed sum to fund its planned psilocybin clinical trials.

Molecule uses blockchain technology to provide an incentive-based market for scientific research. Through Molecule Catalyst, research groups will be able to raise funds for the study of rare diseases, ageing & longevity and psychedelics, among other fields.

To provide an incentive to investors, Molecule uses smart contracts to make the chemical intellectual property resulting from successful products easily tradeable on the Ethereum blockchain. In this way, funders receive a stake in the projects they support—allowing investors of all sizes to help fund potentially pioneering research and benefit from its success. Molecule uses the dollar-backed stablecoin DAI to overcome market instability.

UTM’s psilocybin study is the first fund-raising project to be hosted by Molecule Catalyst, which ultimately aims to create a Web 3.0 marketplace and exchange for chemical IP.

Microdosing research

The UTM study will investigate the effects of microdosing a psychedelic compound known as psilocybin on a variety of cognitive indicators.

Besides examining psilocybin’s effect on creativity, mood and focus, the study will also measure its influence on social connection, self-efficacy and mindfulness.

Overall, UTM hopes that the data produced will help to guide global psychedelics research, by setting a new precedent that can be used to direct impactful psychedelics research.

Previously, psilocybin has been shown to effective in treating a wide variety of mental disorders, ranging from anxiety and depression, to post-traumatic stress disorder (PTSD). However, due to its potential to be abused as a psychedelic drug, the psychoactive substance has been shelved as a potential therapeutic by most pharmaceutical research groups.

Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Mercuriex Cryptocurrency Exchange Launches New Utility Token, SURF

MercuriEx Cryptocurrency Exchange, originally developed in 2017, came under new ownership in December 2019. Since taking over the exchange,...

Fungibility: Bitcoin Mixers Favorite Term That No One Understands

Fungibility, perhaps the most important concept when dealing with a decentralized and anonymous currency, but does bitcoin...

Crypto can’t thrive in the real world – but stablecoins can

We can safely say that the hype about cryptocurrencies is pretty much over. The claims of Bitcoin...

How to double your crypto

Most of us have a small gambler deep inside our souls. We love to feel the thrill...
- Advertisement -Molecule Catalyst and UTM to crowdfund psychedelics research with blockchain

Cryptocurrency Top Security Risk Concerns: What You Can Do to Protect Your Crypto

A report by CipherTrace revealed that in the first half of 2019, criminals and fraudsters stole more...

How has Bitcoin of America Changed the Cryptocurrency Industry?

Who is Bitcoin of America? Bitcoin of America is a U.S. based digital currency...

Must read

Mercuriex Cryptocurrency Exchange Launches New Utility Token, SURF

MercuriEx Cryptocurrency Exchange, originally developed in 2017, came...

Fungibility: Bitcoin Mixers Favorite Term That No One Understands

Fungibility, perhaps the most important concept when...
- Advertisement -Molecule Catalyst and UTM to crowdfund psychedelics research with blockchainMolecule Catalyst and UTM to crowdfund psychedelics research with blockchain

You might also likeRELATED
Recommended to you